Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.86 CNY
4.30 B CNY
22.60 B CNY
3.21 B
About JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD.
Sector
CEO
Hong Bin Dai
Headquarters
Lianyungang
Website
Founded
1970
ISIN
CNE0000014W7
FIGI
BBG000CHFF71
Jiangsu Hengrui Pharmaceuticals Co., Ltd. engages in the research, development, manufacture, and sale of drugs. It specializes in antineoplastic agents, surgical anesthesia drugs, features infusion, contrast agents, and cardiovascular drugs. The firm’s products include tablets, oral solution, and suspension of antineoplastic drugs and narcotic drugs; psychotropic substances; soft capsules; freeze-dried powder injection; powder injection; high-volume injection, including multi-layer co-extruded infusion bag, with anti-tumor drugs; small volume injections, including antineoplastic drugs, psychotropic drugs, and non-final sterilization; biological engineering products such as polyethylene glycol recombinant human granulocyte stimulating factor injection; hard capsules; granules; powder; and film and gel. The company was founded in 1970 and is headquartered in Lianyungang, China.
600276, Jiangsu Hengrui Medicine Co. Ltd. - Trailing StopSSE:600276
Most traders lose money.
Why?
Precisely because rather than simplify their way of operating and be as disciplined as possible, seek solutions that are apparently very technical and professional with the help of indicators and oscillators, and put them on the chart making it very complex
600276, Jiangsu Hengrui Medicine Co. Ltd - Cup & HandleSSE:600276
Classic pattern, Cup & Handle, which in this case acts as a figure of continuation of the primary trend.
Let's take advantage of this breakout of resistance level.
Statistically as we know from our backtest based on our Entry Points, Stop Loss, Take Profit, we have a % positive realizati
600276: JiangSu HengRuiPharmaceuticals have done well in China over the long-term for many years. Given the quality of JiangSu HengRui and its perpetual growth, there is no reason why this trend should abate over the long haul. This stock is immune to a trade war, yet not immune to business cycle risks, which has caused
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 600276 is 49.29 CNY — it has decreased by −0.28% in the past 24 hours. Watch JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD. stocks are traded under the ticker 600276.
600276 stock has risen by 3.51% compared to the previous week, the month change is a −5.45% fall, over the last year JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD. has showed a 1.61% increase.
We've gathered analysts' opinions on JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD. future price: according to them, 600276 price has a max estimate of 123.00 CNY and a min estimate of 44.50 CNY. Watch 600276 chart and read a more detailed JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD. stock forecast: see what analysts think of JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD. and suggest that you do with its stocks.
600276 reached its all-time high on Jan 8, 2021 with the price of 97.39 CNY, and its all-time low was 0.28 CNY and was reached on Jul 8, 2005. View more price dynamics on 600276 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
600276 stock is 3.53% volatile and has beta coefficient of 1.08. Track JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD. stock price on the chart and check out the list of the most volatile stocks — is JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD. there?
Today JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD. has the market capitalization of 313.85 B, it has increased by 3.15% over the last week.
Yes, you can track JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD. financials in yearly and quarterly reports right on TradingView.
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD. is going to release the next earnings report on Apr 21, 2025. Keep track of upcoming events with our Earnings Calendar.
600276 earnings for the last quarter are 0.18 CNY per share, whereas the estimation was 0.19 CNY resulting in a −1.98% surprise. The estimated earnings for the next quarter are 0.24 CNY per share. See more details about JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD. earnings.
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD. revenue for the last quarter amounts to 6.59 B CNY, despite the estimated figure of 6.55 B CNY. In the next quarter, revenue is expected to reach 7.09 B CNY.
600276 net income for the last quarter is 1.19 B CNY, while the quarter before that showed 2.06 B CNY of net income which accounts for −42.42% change. Track more JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD. financial stats to get the full picture.
Yes, 600276 dividends are paid annually. The last dividend per share was 0.20 CNY. As of today, Dividend Yield (TTM)% is 0.40%. Tracking JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD. dividends might help you take more informed decisions.
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD. dividend yield was 0.44% in 2023, and payout ratio reached 29.53%. The year before the numbers were 0.42% and 26.08% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 13, 2024, the company has 19.61 K employees. See our rating of the largest employees — is JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD. on this list?
Like other stocks, 600276 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD. stock shows the buy signal. See more of JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.